Deutsche Bank Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $20
BrightSpring Health Svcs Is Maintained at Outperform by Mizuho
BrightSpring Health Analyst Ratings
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $19
Deutsche Bank Adjusts BrightSpring Health Services Price Target to $20 From $13, Maintains Buy Rating
BrightSpring Health Services: Strong Third-Quarter Performance and Positive Outlook Justify Buy Rating
BofA Securities Adjusts Price Target on BrightSpring Health Services to $16.50 From $14, Maintains Buy Rating
BTIG Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $20
BrightSpring Health Svcs Is Maintained at Buy by Guggenheim
BrightSpring Health Analyst Ratings
Guggenheim Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $18
Wells Fargo Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $17
Buy Rating Affirmed for BrightSpring Health Services Amidst Strategic Share Transaction and Strong Operational Performance
Jefferies Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $18.5
Analysts Are Bullish on Top NA Stocks: BrightSpring Health Services, Inc. (BTSG), American Healthcare REIT, Inc. (AHR)
Analysts Have Conflicting Sentiments on These NA Companies: Nuveen Churchill Direct Lending Corp. (NCDL), Ibotta, Inc. Class A (IBTA) and BrightSpring Health Services, Inc. (BTSG)
Goldman Sachs Maintains Buy on BrightSpring Health, Lowers Price Target to $18
BrightSpring Health Analyst Ratings
Analysts Offer Insights on NA Companies: BrightSpring Health Services, Inc. (BTSG), Reddit Inc Class A (RDDT) and American Healthcare REIT, Inc. (AHR)
Morgan Stanley Sticks to Its Buy Rating for BrightSpring Health Services, Inc. (BTSG)